Donaldson Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.46M | Buy |
13,174
+485
| +4% | +$53.8K | 0.05% | 120 |
|
|
2025
Q1 | $1.42M | Buy |
12,689
+774
| +6% | +$86.7K | 0.05% | 118 |
|
|
2024
Q4 | $1.1M | Sell |
11,915
-105
| -0.9% | -$9.7K | 0.04% | 130 |
|
|
2024
Q3 | $1.01M | Sell |
12,020
-145
| -1% | -$12.2K | 0.04% | 131 |
|
|
2024
Q2 | $835K | Sell |
12,165
-373
| -3% | -$25.6K | 0.04% | 133 |
|
|
2024
Q1 | $918K | Sell |
12,538
-160
| -1% | -$11.7K | 0.04% | 126 |
|
|
2023
Q4 | $1.03M | Sell |
12,698
-197
| -2% | -$16K | 0.05% | 121 |
|
|
2023
Q3 | $966K | Buy |
12,895
+1,298
| +11% | +$97.3K | 0.05% | 124 |
|
|
2023
Q2 | $894K | Buy |
11,597
+714
| +7% | +$55K | 0.04% | 130 |
|
|
2023
Q1 | $903K | Buy |
10,883
+2,258
| +26% | +$187K | 0.04% | 123 |
|
|
2022
Q4 | $740K | Sell |
8,625
-1,915
| -18% | -$164K | 0.04% | 135 |
|
|
2022
Q3 | $650K | Buy |
10,540
+574
| +6% | +$35.4K | 0.04% | 135 |
|
|
2022
Q2 | $616K | Buy |
9,966
+4,203
| +73% | +$260K | 0.03% | 141 |
|
|
2022
Q1 | $343K | Buy |
5,763
+641
| +13% | +$38.2K | 0.02% | 214 |
|
|
2021
Q4 | $372K | Buy |
5,122
+823
| +19% | +$59.8K | 0.02% | 219 |
|
|
2021
Q3 | $300K | Buy |
4,299
+221
| +5% | +$15.4K | 0.02% | 224 |
|
|
2021
Q2 | $281K | Buy |
4,078
+348
| +9% | +$24K | 0.01% | 228 |
|
|
2021
Q1 | $241K | Buy |
+3,730
| New | +$241K | 0.01% | 227 |
|